A Hybrid Emotion-focused Treatment for Chronic Pain Patients With Emotional Problems
CompletedNot applicableNCT02808286
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The aim of this project is to evaluate a hybrid emotion-focused treatment protocol, specifically developed for individuals who suffer from co-occurring chronic pain and clinical levels of anxiety and/or depressive symptoms. Specific questions relating to treatment outcome: 1. Does a hybrid emotion-focused treatment lead to a decrease in comorbid emotional symptoms (pain-related fear, anxiety, depression)? 2. Does a hybrid emotion-focused treatment lead to an increase in functional ability, improvement in work status and decrease in medication use? 3. Does a hybrid emotion-focused treatment lead to better treatment effect on the above outcome variables compared to an active comparison group? Specific questions relating to the process of change: 4. Are therapeutic effects of the hybrid emotion-focused treatment mediated by changes in proposed transdiagnostic emotion regulation process variables (worry, rumination, cognitive and behavioral avoidance, emotional suppression)?
Study details
- Official title
- An Randomized Controlled Trial (RCT) Testing the Effectiveness of a Hybrid Emotion-focused Treatment for Chronic Pain Patients With Co-occurring Emotional Problems
- Conditions
- Interventions
- Behavioral: Hybrid
- Behavioral: internet Cognitive Behavior Therapy (iCBT)
- Sponsor
- Örebro University, Sweden
- Collaborators
- Linkoeping University
- Start date
- 2016-01
- Primary completion
- 2018-09
- Sex
- All
- Age range
- from 18 Years to 70 Years
- Results posted
- No results posted in this snapshot
- Countries
- Sweden
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Chronic musculoskeletal pain (\> 6 months duration), not emanating from malignancies, systemic diseases (e.g. rheumatoid arthritis) or localized single-joint osteoarthritic conditions in the lower extremities (e.g. knee-osteoarthritis, hip- osteoarthritis). * Functional problems due to pain (defined as \> 10 points on question 21-24 of the Orebro Musculoskeletal Pain Questionnaire). * Emotional problems (defined as \>7 points (cut-off for a probable case) on at least one of the two subscales (anxiety and depression) of the Hospital Anxiety and Depression Scale). Exclusion Criteria: * Severe psychiatric disorders that may require immediate other treatment (alcohol abuse, bipolar disorder, psychotic disorders), * Currently in psychological treatment elsewhere, * Recently been started on psychopharmacological treatment for depression and/or anxiety (cut off criterion: \< 3 months prior to planned treatment start), * Insufficient mastery of the Swedish language written as well as spoken, * No personal computer available.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT02808286